Ardelyx (ARDX) Gross Margin Growth (3y) (2018 - 2026)

Ardelyx (ARDX) Gross Margin Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 722.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -162.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ardelyx 1.26 Bn 1.02 Bn 89.66 Mn 843.00

Historic Data

Download Data
DateValue
Mar 31, 2026 843.00
Dec 31, 2025 -151.00
Sep 30, 2025 -10,244.00
Jun 30, 2025 -724.00
Mar 31, 2025 156.00
Dec 31, 2024 -1,573.00
Sep 30, 2024 -1,601.00
Jun 30, 2024 -1,289.00
Mar 31, 2024 -29.00
Dec 31, 2023 -1,455.00
Sep 30, 2023 -1,364.00
Jun 30, 2023 -794.00
Mar 31, 2023 -1,352.00
Dec 31, 2022 -716.00
Sep 30, 2022 523.00
Jun 30, 2022 -546.00
Dec 31, 2021 0.00
Sep 30, 2021 116.00
Jun 30, 2021 0.00
Mar 31, 2021 481.00